Pexacerfont
| CAS No. | 459856-18-9 | Cat. No. | BCP26369 |
| Name | Pexacerfont | ||
| Synonyms | BMS-562086; BMS 562086; BMS562086; BMS-562,086; BMS562,086; BMS 562,086; | ||
| Formula | C18H24N6O | M. Wt | 340.43 |
| Description | Pexacerfont, also known as BMS-562086, is a potent and orally active CRF-1 antagonist. Pexacerfont is a recently developed CRF-1 antagonist which is currently in clinical trials for the treatment of anxiety disorders, and has also been proposed to be useful for the treatment of depression and irritable bowel syndrome. BMS-562086 exhibited favorable ADME and pharmacokinetic properties for further development. | ||
| Pathways | GPCR/G Protein | ||
| Targets | CRFR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.